News | December 27, 2024
Thyrocare secures NABL accreditation for its Labs
Thyrocare becomes first national diagnostic chain with 100% of its labs with NABL accreditation
Thyrocare becomes first national diagnostic chain with 100% of its labs with NABL accreditation
The transaction is expected to result in approximately $175 million to support further development of IMG-007
New capsule manufacturing lines added at Lonza Capsules & Health Ingredients (CHI) facilities in Rewari and Suzhou
Accelerated approval is based on 61% overall response rate compared to 40% in control arm in the
The centre features a cutting-edge climatic chamber for stability testing and spectrophotometry to ensure that products meet the most stringent manufacturing and testing standards
The new facility significantly increases Siegfried’s R&D capacity to drive development excellence and further growth
The program aims to accelerate the development of 6 Indian innovations to improve ease of access to diagnostics and treatment monitoring
The FDA conducted a comprehensive Pre-Approval Inspection (PAI) and cGMP audit
India has been declared ‘functional’ against all the core regulatory functions of the WHO Global Benchmarking Tool Version VI
India’s first trial for a novel autologous BCMA directed CAR-T cell therapy in patients with relapsed / refractory multiple myeloma
Subscribe To Our Newsletter & Stay Updated
